Topotecan for the treatment of relapsed small-cell lung cancer

  • Technology appraisal guidance
  • TA184
  • Published: 
Download guidance (PDF)

Update information

February 2014: Implementation section updated to clarify that topotecan is recommended as an option for treating relapsed small-cell lung cancer.

ISBN: 978-1-4731-5677-7